Protocol Design White Papers & Case Studies
-
Increasing Access To CAR-T Therapy Trifecta: Safety, Efficacy, & Cost
6/19/2023
Review the history and current landscape of CAR T-cell therapy research and development to gain insight from strategies used to increase safety and efficacy while lowering cost.
-
Collaboration Delivers Agility & Results During COVID-19
6/6/2023
Learn how a European multinational pharmaceutical company gained support for several international studies to test its RBD dimer recombinant protein vaccine for SARS-CoV-2.
-
4 Modernized Functions Every Sponsor Needs For Study Startup
5/23/2023
Explore four modern tech capabilities designed to help decrease cycle times, improve processes and compliance, and mitigate site burdens.
-
Advance Drug Development With Nonclinical Services
5/18/2023
Get proximity to world-class nonclinical laboratories and renowned principal investigators to accelerate drug development endeavors with the help of Premier Consulting’s study execution team in Montreal.
-
Chemistry, Manufacturing, & Controls Solutions
5/18/2023
Learn how to streamline the development process, optimize resource allocation, and maximize efficiency, ultimately saving valuable time and financial resources.
-
Drug Development Strategy Solutions
5/18/2023
Navigate complex challenges experienced throughout drug development to ensure a seamless progression and maximize the potential for success in the life sciences industry.
-
De-Risk Development: Nonclinical Strategy And Study Design
5/18/2023
Whether you are a researcher, scientist, or industry professional, access these insightful guides and checklists that provide valuable advice and best practices for planning and executing nonclinical studies.
-
Clario eCOA Participant & Caregiver Training
5/17/2023
Discover how Clario’s patient-centric solution helps improve engagement and ensures consistent training across all participants, at all sites.
-
Training Program Reduces Placebo Effect By More Than 50% In ePRO Study
5/17/2023
Discover how an instruction program directly contributed to significantly lowering the placebo response rate in a phase III migraine CNS study.
-
RNA Therapies – Global Clinical Trial Landscape - Focus On Asia Pacific
5/17/2023
Learn about the global clinical trial landscape of RNA therapy, with emphasis on trends in the Asia Pacific, and recent advancements in the field.